L
Leo Cancer Care
Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes
About Leo Cancer Care
Leo Cancer Care is a medical technology company focused on developing and commercializing a new approach to radiation therapy. The company has developed a range of solutions for both photon and particle therapy that utilize an upright patient positioning system. This method challenges the conventional lie-down treatment approach, aiming to improve patient comfort and treatment accuracy.
The company's product portfolio includes the 'Marie' system, a particle therapy solution that integrates an upright patient positioning platform with a fan beam CT scanner. This system is designed to be 'beam agnostic', allowing for integration with existing fixed-beam radiation therapy technologies. By avoiding the need for large, rotating gantries, the company's solutions can offer significant cost savings to healthcare providers, potentially expanding access to advanced cancer care.
Leo Cancer Care operates in the global oncology market, with a focus on providing more effective and efficient radiotherapy options. The company is actively seeking regulatory clearance for its products, including a pending 510(k) decision from the FDA for its 'Marie' solution, which would allow for its commercialization in the United States.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Horley, United Kingdom
- Employees
- 123
- Open positions
- 9
- Dealroom signal
- 83.8/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Oncology, Spinout, Tech for Hospitals and Clinics, DT and LS, rio ai health, rio AI medical devices, uk rio, uk is8 life sciences, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Sep 2025 | $40M | $160M | Catalio Capital Management | ↗ |
| SERIES COther financing | Jun 2024 | — | — | WARF Ventures · McLaren Health Care · Macmillan Cancer Support · EDB Singapore | ↗ |
Growth signals
Latest recorded traffic for Leo Cancer Care is 6.6K monthly website visits, up 57.1% over the last three months. Leo Cancer Care's team grew 5.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Radiation Solutions
Yu Galaxy
Serra Ventures
WARF Ventures
Alumni Ventures
Asto CT
Junson Capital
Pureland Group Venture
Series B and later6 investors entered at this stage
McLaren Health Care
Macmillan Cancer Support
EDB Singapore
Cone Health
Aviko Radiopharmaceuticals
Catalio Capital Management
Other known investors1 additional known investor
University of Wisconsin-Madison
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Leo Cancer Care on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Leo Cancer Care’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.